Apellis Pharmaceuticals, Inc.
(APLS - NASDAQ)
40,95 USD
📋 Profilo Aziendale

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases.

|